EAACI Congress 2025
BackTPS52 - Allergy diagnosis 11
Sunday 15 Jun, 12:45 PM -
13:45 PM Glasgow, United Kingdom
Poster Zone
Thematic Poster Session
D3.18
Allergy to Isobornyl Acrylate (IBOA) present in Sensors and Insulin Infusion Systems in Pediatric Population
D3.26
Anaphylaxis associated with biosimilar Tocilizumab: in vitro and in vivo diagnosis
D3.27
Chlorhexidine as a Hidden Everyday Allergen
D3.28
Comparative Efficacy and Safety of Omalizumab Intended copy Biosimilar vs. Biologic in Chronic Spontaneous Urticaria
D3.23
Descriptive and Comparative Analysis of Clinical and Endoscopic Characteristics and Treatment Response in Adult Patients with Eosinophilic Esophagitis (EoE): a preliminary experience of an Italian centre
D3.29
Detailed Clinical Characterization of a Large Cohort of Chronic Spontaneous Urticaria Patients
D3.19
Evaluation of allergens in Atopic Dermatitis in children between 6 months and 18years
D3.22
Fixed Drug Eruption in a Patient with Vitiligo: localized patch testing as a diagnostic tool
D3.30
Fixed drug eruption: exploring diagnostic considerations and triggers in a cohort study
D3.24
From angioedema to Kimura disease: Diagnostic challenge
D3.20
Searching for an Alternative Contrast Agent in a Patient Allergic to Multiple Nonionic Iodinated Contrast Media
D3.33
Severe Eosinophilic Esophagitis: the Key Role of Biologics in Disease Management
D3.31
Successful Management of Primary Cold Urticaria in Medical Practitioners: A Small Case Series
D3.17
Systemic Histaminergic Findings in Children with Chronic Urticaria
